"Urogenital Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the UROGENITAL SYSTEM in either the male or the female.
| Descriptor ID |
D014565
|
| MeSH Number(s) |
C04.588.945 C12.758 C13.351.937
|
| Concept/Terms |
Urogenital Neoplasms- Urogenital Neoplasms
- Neoplasm, Urogenital
- Urogenital Neoplasm
- Neoplasms, Urogenital
- Genito-urinary Neoplasm
- Genito-urinary Neoplasms
- Neoplasm, Genito-urinary
- Neoplasms, Genito-urinary
- Genitourinary Neoplasms
- Genitourinary Neoplasm
- Neoplasm, Genitourinary
- Neoplasms, Genitourinary
Genitourinary Cancer- Genitourinary Cancer
- Cancer, Genitourinary
- Cancers, Genitourinary
- Genitourinary Cancers
- Genito-urinary Cancer
- Cancer, Genito-urinary
- Cancers, Genito-urinary
- Genito urinary Cancer
- Genito-urinary Cancers
- Urogenital Cancer
- Cancer, Urogenital
- Cancers, Urogenital
- Urogenital Cancers
|
Below are MeSH descriptors whose meaning is more general than "Urogenital Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Urogenital Neoplasms".
This graph shows the total number of publications written about "Urogenital Neoplasms" by people in this website by year, and whether "Urogenital Neoplasms" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2002 | 3 | 0 | 3 |
| 2005 | 3 | 2 | 5 |
| 2006 | 4 | 1 | 5 |
| 2007 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 2 | 0 | 2 |
| 2011 | 1 | 0 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 3 | 0 | 3 |
| 2014 | 2 | 0 | 2 |
| 2015 | 2 | 0 | 2 |
| 2016 | 1 | 1 | 2 |
| 2018 | 4 | 0 | 4 |
| 2019 | 6 | 0 | 6 |
| 2020 | 6 | 0 | 6 |
| 2023 | 1 | 0 | 1 |
| 2024 | 5 | 0 | 5 |
Below are the most recent publications written about "Urogenital Neoplasms" by people in Profiles.
-
Novel Radiopharmaceuticals and Future of Theranostics in Genitourinary Cancers. Eur Urol. 2025 Feb; 87(2):125-139.
-
MicroRNAs in Genitourinary Malignancies: An Exciting Frontier of Cancer Diagnostics and Therapeutics. Int J Mol Sci. 2024 Aug 31; 25(17).
-
Final Results From a Phase I Trial and Expansion Cohorts of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced/Metastatic Genitourinary Tumors. J Clin Oncol. 2024 Sep 01; 42(25):3033-3046.
-
Diversifying editorial boards to mitigate the global burden of genitourinary cancers. Nat Rev Urol. 2024 07; 21(7):385-386.
-
Utilization of a Third-party Partnership in Tele-genetic Risk Assessment Program in Genitourinary Oncology. Urology. 2024 Sep; 191:95-100.
-
MicroRNAs for detecting occult genitourinary cancer. Curr Opin Urol. 2024 Jan 01; 34(1):20-26.
-
Circulating Tumor Cell Subtypes and T-cell Populations as Prognostic Biomarkers to Combination Immunotherapy in Patients with Metastatic Genitourinary Cancer. Clin Cancer Res. 2021 03 01; 27(5):1391-1398.
-
Results of a multicenter, phase 2 study of nivolumab and ipilimumab for patients with advanced rare genitourinary malignancies. Cancer. 2021 03 15; 127(6):840-849.
-
Phase I Study of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced or Metastatic Urothelial Carcinoma and Other Genitourinary Tumors. J Clin Oncol. 2020 11 01; 38(31):3672-3684.
-
The Impact of the COVID-19 Pandemic on Genitourinary Cancer Care: Re-envisioning the Future. Eur Urol. 2020 11; 78(5):731-742.